← Back to Clinical Trials
Recruiting NCT05881798

NCT05881798 Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05881798
Status Recruiting
Phase
Sponsor Cook Research Incorporated
Condition Deep Vein Thrombosis
Study Type OBSERVATIONAL
Enrollment 82 participants
Start Date 2025-06-02
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Celect Platinum Vena Cava Filter

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 82 participants in total. It began in 2025-06-02 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.

Eligibility Criteria

Inclusion Criteria: * A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava Filter is placed * Subject has not previously participated in the Cook MDR-2126 study. Exclusion Criteria: * Patients will be excluded from enrollment if the patient or his/her legally authorized representative objects to collection and processing of his/her data or is not willing to sign the Informed Consent.

Contact & Investigator

Central Contact

Sabina Andersen

✉ sabina.hjorth@cookmedical.com

📞 +45 29 73 41 34

Frequently Asked Questions

Who can join the NCT05881798 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Deep Vein Thrombosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05881798 currently recruiting?

Yes, NCT05881798 is actively recruiting participants. Contact the research team at sabina.hjorth@cookmedical.com for enrollment information.

Where is the NCT05881798 trial being conducted?

This trial is being conducted at Los Angeles, United States, Barcelona, Spain, Córdoba, Spain, Sabadell, Spain and 3 additional locations.

Who is sponsoring the NCT05881798 clinical trial?

NCT05881798 is sponsored by Cook Research Incorporated. The trial plans to enroll 82 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology